Back to search

Belgium· BE-AMP-SAM188325-00

Atenolol Viatris 50 mg

A atenolol product containing atenolol, registered in Belgium by Viatris GX. The same ATC class is registered in 17 of our 19 countries.

ATC C07AB03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAtenolol Viatris 50 mgATCC07AB03REGISTER NO.BE-AMP-SAM188325-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Atenolol is registered in 17 of 19 countries.

Countries holding a registration under ATC C07AB03 (atenolol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose

Atenolol · ATC C07AB03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of atenolol costs, country by country.

Normalised to the WHO defined daily dose (75 mg), the median price runs from $0.071 in Spain to $0.58 in Switzerland — a ×8.2 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Atenolol · price per daily dose (75 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.58
  • FR France$0.12
  • IT Italy$0.11
  • ES Spain$0.071
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Atenolol
Manufacturer
Viatris GX
Country
Belgium (BE)
ATC code
C07AB03
ATC class
Atenolol
Defined daily dose
75 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    1537083
  • be_apb
    0763599

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

428 interactions on record for atenolol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Atenolol · interactions on record

428 records

  • 11 severe
  • 181 moderate
  • 20 minor
  • 174 info

Most severe, free to view

  • DolasetronA04AA04severe
  • TheophyllinC01EB28severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe

42 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Atenolol in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atenolol products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Atenolan, Atenolol 1a Pharma
  • Bulgaria · Атенолол Софарма
  • Cyprus · Ikelan, Vascoten
  • Czechia · Atehexal, Atenobene
  • Germany · Atenolol 1 A Pharma, Atenolol Abz
  • Denmark · Atenodan, Atenolol Medical Valley
  • Estonia · Atenolol Ratiopharm
  • Spain · Atenolol Alter, Atenolol Aurovitas
  • Finland · Atenblock, Tenoprin
  • France · Atenolol Accord Healthcare, Atenolol Arrow
  • United Kingdom (Northern Ireland) · Atenol Special Concept Development (Uk), Atenolol
  • Greece · Azectol, Neocardon
  • Croatia · Atenolol Pliva, Ormidol
  • Hungary · Atenobene, Prinorm
  • Ireland · Atecor, Atenomel
  • Iceland · Atenolol Viatris
  • Italy · Atenol, Atenololo Abc
  • Lithuania · Atenolol Ratiopharm, Ikelan
  • Luxembourg · Atenolol Eg, Tenormin
  • Malta · Atecor, Atenolol
  • Netherlands · Atenolol Accord, Atenolol Aurobindo
  • Norway · Atenolol Medical Valley, Atenolol Viatris
  • Portugal · Atenlolol Ratiopharm, Atenolol Alter
  • Romania · Atenolol Arena, Atenolol Lph Labermomed
  • Sweden · Atenolol Accord, Atenolol Medical Valley
  • Slovenia · Ormidol
  • Slovakia · Atenobene

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8f8bf79a-ccde-4486-8aa0-062c94cd2b62
GET /v1/drugs/8f8bf79a-ccde-4486-8aa0-062c94cd2b62?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Atenolol Viatris 50 mg",
  "name_fr": "Atenolol Viatris 50 mg",
  "name_nl": "Atenolol Viatris 50 mg",
  "amp_code": "SAM188325-00",
  "strengths": [
    "50.0000",
    "50.0000",
    "50.0000",
    "50.0000",
    "2.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Atenolol",
    "Sodium Starch Glycolate (Type A)"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Atenolol",
  "authorisation_numbers": [
    "BE188325"
  ]
}

See everything about atenolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.